Cambrex Corp. (CBM) Tops Q1 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cambrex Reports First Quarter 2019 Financial Results
May 2, 2019 6:40 AM EDT- Acquired Avista Pharma Solutions, broadening capabilities, enhancing revenue growth and expanding customer base -
- Reaffirms full year financial guidance -
- Conference call at 8:30 a.m. ET on May 2, 2019 -
EAST RUTHERFORD, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, reports results for the first quarter ended March 31, 2019.
First Quarter 2019 Highlights
Completed the... More